TEKTURNA Side Effects

6974573-9 | Alopecia, Condition Aggravated, Cystitis Interstitial, Dysuria, Micturition Urgency
on Sep 09, 2010 Female patient from UNITED STATES , 62 years of age, weighting 170.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, condition aggravated, cystitis interstitial, dysuria, micturition urgency. Tekturna dosage: 150 Mg Once Daily Po.

6929769-9 | Chronic Hepatitis, Hepatic Necrosis
Patient was taking Tekturna (View Usage). Patient had the following side effects: chronic hepatitis, hepatic necrosis on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, . Tekturna dosage: . During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), NORVASC (View Norvasc Review and Norvasc Label ), BENECAR (View Benecar Review and Benecar Label ).

6913471-3 | Blood Pressure Increased, Fear Of Disease, Heart Rate Increased
Adverse event was reported on Aug 04, 2010 by a Female patient taking Tekturna (View Usage) (Dosage: 150mg ? 1-day Mouth) was diagnosed with hypertension and. Location: UNITED STATES , 65 years of age, weighting 165.0 lb, After Tekturna was administered, patient had the following side effects: blood pressure increased, fear of disease, heart rate increased. Patient was hospitalized.

6875087-7 | Toxic Epidermal Necrolysis
on Jul 13, 2010 Female patient from UNITED STATES , weighting 192.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Tekturna dosage: 150 Mg Qd. Patient was hospitalized.


6862131-6 | Arthralgia, Multi-organ Failure, Pyrexia, Stevens-johnson Syndrome, Swelling
on Jul 14, 2010 Female patient from UNITED STATES , 70 years of age, was treated with Tekturna (View Usage). Patient had the following side effects: arthralgia, multi-organ failure, pyrexia, stevens-johnson syndrome, swelling. Tekturna dosage: Unk. During the same period patient was treated with FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6856426-X | Blood Sodium Decreased
Patient was taking Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: blood sodium decreased on Jul 06, 2010 from UNITED STATES Additional patient health information: Female patient , 91 years of age, . Tekturna dosage: 150 Mg, Qd.

6734363-9 | Dizziness, Hypotension, Hypovolaemia, Nausea, Renal Failure, Renal Tubular Necrosis
Adverse event was reported on Apr 09, 2010 by a Male patient taking Tekturna (View Usage) (Dosage: Unk) was diagnosed with prophylaxis, chronic obstructive pulmonary disease, depression (What is depression?), hypertension, type 2 diabetes mellitus, hyperlipidaemia, muscle spasms and. Location: UNITED STATES , 60 years of age, weighting 233.0 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypotension, hypovolaemia, nausea (What is nausea?), renal failure, renal tubular necrosis. During the same period patient was treated with NEXIUM (Unk) (View Nexium Review and Nexium Label ), SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ), PAXIL (Unk) (View Paxil Review and Paxil Label ), BYSTOLIC (Unk) (View Bystolic Review and Bystolic Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ), GLUCOPHAGE (Unk) (View Glucophage Review and Glucophage Label ), LOVAZA (Unk) (View Lovaza Review and Lovaza Label ), MAGNESIUM OXIDE (Unk) (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6724831-8 | Renal Failure Acute, Rhabdomyolysis
on May 13, 2010 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with hypertension, hyperlipidaemia and was treated with Tekturna (View Usage). Patient had the following side effects: renal failure acute, rhabdomyolysis. Tekturna dosage: 150 Mg Q Day Po. During the same period patient was treated with VYTORIN (10/40mg Q Day Po) (View Vytorin Review and Vytorin Label ). Patient was hospitalized.

6719139-0 | Alopecia, Cardiac Valve Disease, Dialysis, Dysuria, Onychomadesis, Pruritus, Renal Disorder
on May 10, 2010 Female patient from UNITED STATES , weighting 117.0 lb, was diagnosed with cystitis and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: alopecia, cardiac valve disease, dialysis (What is dialysis?), dysuria, onychomadesis, pruritus, renal disorder. Tekturna dosage: . During the same period patient was treated with KEFLEX (View Keflex Review and Keflex Label ). Patient was hospitalized.

6676436-5 | Bronchospasm, Cough
Patient was taking Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, cough on Mar 31, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 220.0 lb, . Tekturna dosage: 300 (units Not Specified), Qd. During the same period patient was treated with DIOVAN (320 (units Not Specified)) (View Diovan Review and Diovan Label ).

6674544-6 | Asthenia, Cystitis, Dialysis, Haemorrhage, Inflammation, Malaise, Weight Decreased
Adverse event was reported on Mar 31, 2010 by a Female patient taking Tekturna (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 89.98 lb, Patient had the following side effects: asthenia, cystitis, dialysis (What is dialysis?), haemorrhage, inflammation, malaise, weight decreased. During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), ARICEPT (10 Mg) (View Aricept Review and Aricept Label ), NAMOXDIL (View Namoxdil Review and Namoxdil Label ), PLAVIX (75 Mg) (View Plavix Review and Plavix Label ), PROCARDIA (60 Mg) (View Procardia Review and Procardia Label ), CELEBREX (100 Mg) (View Celebrex Review and Celebrex Label ), POTONIX (View Potonix Review and Potonix Label ), MEGESTROL ACETATE (View Megestrol Acetate Review and Megestrol Acetate Label ). Patient was hospitalized.

6661473-7 | Anaphylactic Shock, Angioedema, Cardio-respiratory Arrest, Dysphagia, Dyspnoea, Hypotension, Odynophagia, Pharyngeal Oedema
on Mar 26, 2010 Female patient from UNITED STATES , 80 years of age, weighting 178.0 lb, was diagnosed with hypertension, diabetes mellitus, diabetic nephropathy and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: anaphylactic shock, angioedema, cardio-respiratory arrest, dysphagia, dyspnoea, hypotension, odynophagia, pharyngeal oedema. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with COZAAR (100 Mg, Qd) (View Cozaar Review and Cozaar Label ), LISINOPRIL (60 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), DIGOXIN (Unk, Unk) (View Digoxin Review and Digoxin Label ), PROTONIX (Unk, Unk) (View Protonix Review and Protonix Label ).

6654081-5 | Dyspnoea
on Mar 18, 2010 Female patient from UNITED STATES , 72 years of age, weighting 176.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with TOPROL XL (100 Mg, Tid) (View Toprol-xl Review and Toprol-xl Label ), CLONIDINE (0.1 Mg, Bid) (View Clonidine Review and Clonidine Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), DUONEB (View Duoneb Review and Duoneb Label ), PREMARIN (View Premarin Review and Premarin Label ), FLOMAX (View Flomax Review and Flomax Label ), LEXAPRO (View Lexapro Review and Lexapro Label ).

6649969-5 | Flushing, Paraesthesia, Paraesthesia Oral, Pharyngeal Disorder, Throat Tightness
Patient was taking Tekturna (View Usage). Patient had the following side effects: flushing, paraesthesia, paraesthesia oral, pharyngeal disorder, throat tightness on Mar 24, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 293.0 lb, was diagnosed with hypertension and. Tekturna dosage: 150mg One Qd Oral. Patient was hospitalized.

6644166-1 | Arrhythmia, Blood Creatinine Increased
Adverse event was reported on Mar 17, 2010 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension, cardiac failure and. Location: UNITED STATES , weighting 143.3 lb, After Tekturna was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), blood creatinine increased. During the same period patient was treated with INSULIN (Unk, Unk) (View Insulin Review and Insulin Label ), CLONIDINE (0.2 Mg, Bid) (View Clonidine Review and Clonidine Label ), HYDRALAZINE HCL (75 Mg, Tid) (View Hydralazine Hcl Review and Hydralazine Hcl Label ), MINOXIDIL (Unk, Unk) (View Minoxidil Review and Minoxidil Label ), VYTORIN (View Vytorin Review and Vytorin Label ), LANTUS (View Lantus Review and Lantus Label ), PREVACID (View Prevacid Review and Prevacid Label ).

6637962-8 | Arrhythmia, Blood Creatinine Increased
on Mar 14, 2010 Female patient from UNITED STATES , 24 years of age, weighting 130.0 lb, was diagnosed with hypertension, cardiac failure and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), blood creatinine increased. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with INSULIN (Unk, Unk) (View Insulin Review and Insulin Label ), CLONIDINE (Unk, Unk) (View Clonidine Review and Clonidine Label ), HYDRALAZINE HCL (Unk, Unk) (View Hydralazine Hcl Review and Hydralazine Hcl Label ), MINOXIDIL (Unk, Unk) (View Minoxidil Review and Minoxidil Label ).

6635899-1 | Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Myopathy, Pneumonia
on Mar 04, 2010 Male patient from UNITED STATES , 93 years of age, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, liver function test abnormal, myopathy, pneumonia (What is pneumonia?). Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with VYTORIN (10/80) (View Vytorin Review and Vytorin Label ). Patient was hospitalized.

6633072-4 | Dyspnoea
Patient was taking Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: dyspnoea on Mar 01, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 176.0 lb, was diagnosed with hypertension and. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with TOPROL XL (100 Mg, Tid) (View Toprol-xl Review and Toprol-xl Label ), CLONIDINE (0.1 Mg, Bid) (View Clonidine Review and Clonidine Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), DUONEB (View Duoneb Review and Duoneb Label ), PREMARIN (View Premarin Review and Premarin Label ), FLOMAX (View Flomax Review and Flomax Label ), LEXAPRO (View Lexapro Review and Lexapro Label ).

6616433-9 | Angioedema, Cardio-respiratory Arrest, Dysphagia, Dyspnoea, Pharyngeal Oedema
Adverse event was reported on Mar 02, 2010 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension, diabetes mellitus, diabetic nephropathy and. Location: UNITED STATES , 80 years of age, weighting 178.0 lb, Patient experienced the following unwanted or unexpected effects: angioedema, cardio-respiratory arrest, dysphagia, dyspnoea, pharyngeal oedema. During the same period patient was treated with COZAAR (50 Mg/h, Qd) (View Cozaar Review and Cozaar Label ), LISINOPRIL (20 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), DIGOXIN (Unk, Unk) (View Digoxin Review and Digoxin Label ), PROTONIX (Unk, Unk) (View Protonix Review and Protonix Label ).

6606489-1 | Asthenia, Cystitis, Dialysis, Haemorrhage, Malaise, Weight Decreased
on Feb 19, 2010 Female patient from UNITED STATES , weighting 89.98 lb, was treated with Tekturna (View Usage). Patient had the following side effects: asthenia, cystitis, dialysis (What is dialysis?), haemorrhage, malaise, weight decreased. Tekturna dosage: . During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), ARICEPT (View Aricept Review and Aricept Label ), NAMOXDIL (View Namoxdil Review and Namoxdil Label ), PLAVIX (View Plavix Review and Plavix Label ), PROCARDIA (View Procardia Review and Procardia Label ), CELEBREX (View Celebrex Review and Celebrex Label ), POTONIX (View Potonix Review and Potonix Label ), MEGESTROL ACETATE (View Megestrol Acetate Review and Megestrol Acetate Label ). Patient was hospitalized.

6580346-1 | Blood Creatinine Increased, Blood Potassium Increased, Glomerular Filtration Rate Decreased, Protein Urine Present, Proteinuria
on Feb 01, 2010 Female patient from UNITED STATES , 69 years of age, was diagnosed with hypertension and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: blood creatinine increased, blood potassium increased, glomerular filtration rate decreased, protein urine present, proteinuria. Tekturna dosage: Unk. During the same period patient was treated with DIOVAN (Unk, Unk) (View Diovan Review and Diovan Label ), HYDROCHLOROTHIAZIDE (Unk, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6534418-8 | Cough, Dyspnoea, Fatigue, Feeling Abnormal, Gastrointestinal Disorder, Hypertension, Influenza, Malaise
Patient was taking Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, fatigue, feeling abnormal, gastrointestinal disorder, hypertension, influenza, malaise on Jan 08, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, was diagnosed with hypertension and. Tekturna dosage: . During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ).

6474244-1 | Atrial Fibrillation, Blood Albumin Decreased, Blood Creatinine Increased, Blood Glucose Increased, Blood Magnesium Decreased, Blood Potassium Increased, Blood Sodium Decreased, Blood Urea Increased, Bradycardia
Adverse event was reported on Nov 24, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension, blood pressure management and. Location: UNITED STATES , weighting 140.0 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood albumin decreased, blood creatinine increased, blood glucose increased, blood magnesium decreased, blood potassium increased, blood sodium decreased, blood urea increased, bradycardia. During the same period patient was treated with AVALIDE (300/25mg, Qhs) (View Avalide Review and Avalide Label ), TOPROL XL (50 Mg, Bid) (View Toprol-xl Review and Toprol-xl Label ), TENEX (2 Tablets, Daily) (View Tenex Review and Tenex Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LEVOTHROID (50 Mcg Q Day) (View Levothroid Review and Levothroid Label ), FOLIC ACID (Qd) (View Folic Acid Review and Folic Acid Label ), GLIPIZIDE (5 Mg, Tid) (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6459965-9 | Dyspnoea, Face Oedema, Rash
on Nov 17, 2009 Female patient from UNITED STATES , 49 years of age, was diagnosed with hypertension and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: dyspnoea, face oedema, rash (What is rash?). Tekturna dosage: 300 Mg, Qd. During the same period patient was treated with DYAZIDE (Unk, Unk) (View Dyazide Review and Dyazide Label ), ATENOLOL (Unk, Unk) (View Atenolol Review and Atenolol Label ), CLONIDINE (Unk, Unk) (View Clonidine Review and Clonidine Label ).

6457570-1 | Condition Aggravated, Nephrolithiasis
on Nov 16, 2009 Male patient from UNITED STATES , weighting 239.0 lb, was diagnosed with hypertension, arthropathy and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, nephrolithiasis. Tekturna dosage: 150 Mg, Qd Or 300mg 1/2/d. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, 1 Qod) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LOTREL (Amlo5/benaz20, 1 Qd) (View Lotrel Review and Lotrel Label ), LOVAZA (1 Gm, Bid) (View Lovaza Review and Lovaza Label ), VITAMINS NOS (Unk) (View Vitamins Nos Review and Vitamins Nos Label ), ULTRAM (50 1-2, Tid Prn) (View Ultram Review and Ultram Label ), LODINE XL (400 Mg, 1 Bid Prn) (View Lodine Xl Review and Lodine Xl Label ), ASPIRIN (81 Mg, 1 Qd) (View Aspirin Review and Aspirin Label ), LODRANE (24 Unk, 1 Qd) (View Lodrane Review and Lodrane Label ).

6443003-8 | Activities Of Daily Living Impaired, Blood Osmolarity Increased, Confusional State, Gastrointestinal Disorder, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Nervous System Disorder, Oedema
Patient was taking Tekturna (View Usage). Patient had the following side effects: activities of daily living impaired, blood osmolarity increased, confusional state, gastrointestinal disorder, hyponatraemia, inappropriate antidiuretic hormone secretion, nervous system disorder, oedema on Nov 06, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 160.0 lb, was diagnosed with hypertension and. Tekturna dosage: 300 Mg, Qd. During the same period patient was treated with ACCUPRIL (Unk, Unk) (View Accupril Review and Accupril Label ), CAPOTEN (Unk, Prn) (View Capoten Review and Capoten Label ), DILANTIN (400 Mg, Qd) (View Dilantin Review and Dilantin Label ), DEPAKOTE (1250 Mg, Qd) (View Depakote Review and Depakote Label ), PHENOBARBITAL (90 Mg, Qd) (View Phenobarbital Review and Phenobarbital Label ), LEVOCARNITINE (Unk, Unk) (View Levocarnitine Review and Levocarnitine Label ).

6438247-5 | Cerebrovascular Accident, Oedema Peripheral, Phlebitis, Swelling
Adverse event was reported on Oct 29, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 75 Mg, Qd) was diagnosed with hypertension and. Location: UNITED STATES , weighting 126.0 lb, After Tekturna was administered, patient had the following side effects: cerebrovascular accident, oedema peripheral, phlebitis, swelling. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), SIASOL (View Siasol Review and Siasol Label ).

6419274-0 | Blood Pressure Diastolic Increased, Thalamus Haemorrhage
on Oct 15, 2009 Female patient from UNITED STATES , 63 years of age, was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure diastolic increased, thalamus haemorrhage. Tekturna dosage: 300 Mg, Qd. During the same period patient was treated with COREG (3.125 Mg, Bid) (View Coreg Review and Coreg Label ). Patient was hospitalized.

6418582-7 | Nasal Congestion, Periorbital Oedema, Swelling Face
on Oct 15, 2009 Male patient from UNITED STATES , weighting 203.0 lb, was treated with Tekturna (View Usage). Patient had the following side effects: nasal congestion, periorbital oedema, swelling face. Tekturna dosage: 150 Mg, Unk.

6404561-2 | Activities Of Daily Living Impaired, Confusional State, Gastrointestinal Disorder, Hyponatraemia, Nervous System Disorder, Oedema, Weight Increased
Patient was taking Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: activities of daily living impaired, confusional state, gastrointestinal disorder, hyponatraemia, nervous system disorder, oedema, weight increased on Oct 07, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 160.0 lb, was diagnosed with hypertension and. Tekturna dosage: 300 Mg, Qd. During the same period patient was treated with ACCUPRIL (Unk, Unk) (View Accupril Review and Accupril Label ), CAPOTEN (Unk, Prn) (View Capoten Review and Capoten Label ), DILANTIN (400 Mg, Qd) (View Dilantin Review and Dilantin Label ), DEPAKOTE (1250 Mg, Qd) (View Depakote Review and Depakote Label ), PHENOBARBITAL (90 Mg, Qd) (View Phenobarbital Review and Phenobarbital Label ), LEVOCARNITINE (Unk, Unk) (View Levocarnitine Review and Levocarnitine Label ).

6402219-7 | Arteriosclerosis
Adverse event was reported on Apr 10, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 300 Mg, Qd) was diagnosed with hypertension and. Location: UNITED STATES , weighting 135.8 lb, Patient experienced the following unwanted or unexpected effects: arteriosclerosis. During the same period patient was treated with CARDURA /IRE/ (7 Mg, Bid) (View Cardura /ire/ Review and Cardura /ire/ Label ), ZYRTEC (10 Mg, Bid) (View Zyrtec Review and Zyrtec Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), ISORDIL (20 Mg, Tid) (View Isordil Review and Isordil Label ), CLONIDINE (.02 Mg, Tid) (View Clonidine Review and Clonidine Label ), COREG (12.5 Mg, Bid) (View Coreg Review and Coreg Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ).

6395685-7 | Condition Aggravated, Nephrolithiasis
on Sep 29, 2009 Male patient from UNITED STATES , weighting 239.0 lb, was diagnosed with hypertension, arthropathy and was treated with Tekturna (View Usage). Patient had the following side effects: condition aggravated, nephrolithiasis. Tekturna dosage: 150 Mg, Qd Or 300mg 1/2/d. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, 1 Qod) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LOTREL (Amlo5/benaz20, 1 Qd) (View Lotrel Review and Lotrel Label ), LOVAZA (1 Gm, Bid) (View Lovaza Review and Lovaza Label ), VITAMINS NOS (Unk) (View Vitamins Nos Review and Vitamins Nos Label ), ULTRAM (50 1-2, Tid Prn) (View Ultram Review and Ultram Label ), LODINE XL (400 Mg, 1 Bid Prn) (View Lodine Xl Review and Lodine Xl Label ), ASPIRIN (81 Mg, 1 Qd) (View Aspirin Review and Aspirin Label ), LODRANE (24 Unk, 1 Qd) (View Lodrane Review and Lodrane Label ).

6382976-9 | Swollen Tongue
on Sep 28, 2009 Male patient from UNITED STATES , 55 years of age, weighting 222.0 lb, was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: swollen tongue. Tekturna dosage: 300 Mg Once Po. During the same period patient was treated with LISINOPRIL (40 Mg Once Po) (View Lisinopril Review and Lisinopril Label ).

6347930-1 | Vision Blurred
Patient was taking Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: vision blurred on Aug 31, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 159.0 lb, was diagnosed with hypertension and. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with MICARDIS (Unk, Unk) (View Micardis Review and Micardis Label ), TOPROL XL (Unk, Unk) (View Toprol-xl Review and Toprol-xl Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6346234-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Albumin Decreased, Blood Creatinine Increased, Blood Glucose Increased, Blood Magnesium Decreased, Blood Potassium Increased, Blood Sodium Decreased
Adverse event was reported on Sep 03, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension, blood pressure management and. Location: UNITED STATES , weighting 140.0 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood albumin decreased, blood creatinine increased, blood glucose increased, blood magnesium decreased, blood potassium increased, blood sodium decreased. During the same period patient was treated with AVALIDE (300/25mg, Qhs) (View Avalide Review and Avalide Label ), TOPROL XL (50 Mg, Bid) (View Toprol-xl Review and Toprol-xl Label ), TENEX (2 Tablets, Daily) (View Tenex Review and Tenex Label ). Patient was hospitalized.

6343848-9 | Vision Blurred
on Aug 31, 2009 Male patient from UNITED STATES , weighting 159.0 lb, was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: vision blurred. Tekturna dosage: 150 Mg, Unk. During the same period patient was treated with MICARDIS (Unk, Unk) (View Micardis Review and Micardis Label ), TOPROL XL (Unk, Unk) (View Toprol-xl Review and Toprol-xl Label ).

6338892-1 | Nasal Congestion, Periorbital Oedema, Swelling Face
on Aug 27, 2009 Male patient from UNITED STATES , weighting 203.0 lb, was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: nasal congestion, periorbital oedema, swelling face. Tekturna dosage: 150 Mg, Unk.

6334772-6 | Bradycardia, Gamma-glutamyltransferase Increased, Hepatic Enzyme Increased
Patient was taking Tekturna (View Usage). Patient had the following side effects: bradycardia, gamma-glutamyltransferase increased, hepatic enzyme increased on Aug 25, 2009 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with blood pressure management and. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with AVALIDE (Unk, Unk) (View Avalide Review and Avalide Label ).

6332092-7 | Tinnitus
Adverse event was reported on Aug 27, 2009 by a Male patient taking Tekturna (View Usage) (Dosage: 300 Mg Ay Po) was diagnosed with hypertension and. Location: UNITED STATES , 49 years of age, weighting 185.0 lb, After Tekturna was administered, patient had the following side effects: tinnitus (What is tinnitus?).

6322821-0 | Nasal Congestion, Periorbital Oedema, Swelling Face
on Aug 17, 2009 Male patient from UNITED STATES , 94 years of age, was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: nasal congestion, periorbital oedema, swelling face. Tekturna dosage: 150 Mg, Unk.

6301270-5 | Myalgia, Pain, Paralysis
on Aug 06, 2009 Female patient from UNITED STATES , 76 years of age, weighting 150.0 lb, was diagnosed with diabetes mellitus, hypertension and was treated with Tekturna (View Usage). Patient had the following side effects: myalgia, pain (What is pain?), paralysis (What is paralysis?). Tekturna dosage: 1 Tb Daily Daily By Mouth.

6286663-7 | Dizziness, Hyperkalaemia, Renal Failure Acute, Urinary Tract Infection
Patient was taking Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: dizziness (What is dizziness?), hyperkalaemia, renal failure acute, urinary tract infection (What is urinary tract infection?) on Jul 22, 2009 from UNITED STATES Additional patient health information: Female patient , 67 years of age, . Tekturna dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6268909-4 | Blood Calcium Decreased, Blood Creatinine Increased, Blood Glucose Increased, Blood Potassium Increased, Blood Urea Increased, Blood Uric Acid Increased, C-reactive Protein Increased, Carbon Dioxide Decreased, Dehydration
Adverse event was reported on Jul 09, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: blood calcium decreased, blood creatinine increased, blood glucose increased, blood potassium increased, blood urea increased, blood uric acid increased, c-reactive protein increased, carbon dioxide decreased, dehydration. During the same period patient was treated with AVALIDE (300/25 Mg, Daily) (View Avalide Review and Avalide Label ), LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ), KENALOG (0.1 %, Bid) (View Kenalog Review and Kenalog Label ), UTIRA (1 Tablet, Bid - Tid) (View Utira Review and Utira Label ), VOLTAREN /00372303/ (75 Mg, Bid) (View Voltaren /00372303/ Review and Voltaren /00372303/ Label ). Patient was hospitalized.

6266988-1 | Blood Creatinine Increased, C-reactive Protein Increased, Dehydration, Red Blood Cell Sedimentation Rate Increased, Renal Failure Acute
on Jul 06, 2009 Female patient from UNITED STATES , 80 years of age, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient had the following side effects: blood creatinine increased, c-reactive protein increased, dehydration, red blood cell sedimentation rate increased, renal failure acute. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with AVALIDE (300/25 Mg, Unk) (View Avalide Review and Avalide Label ), CIPRO (500 Mg, Bid) (View Cipro Review and Cipro Label ), LIPITOR (10 Mg, Unk) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6266330-6 | Dyspnoea, Feeling Abnormal, Panic Attack, Vital Capacity Decreased
on Jul 07, 2009 Male patient from UNITED STATES , weighting 249.8 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: dyspnoea, feeling abnormal, panic attack, vital capacity decreased. Tekturna dosage: 150 Mg, Unk. During the same period patient was treated with AMLODIPINE (10 Mg) (View Amlodipine Review and Amlodipine Label ), DIOVAN (320/25) (View Diovan Review and Diovan Label ), SIMVASTATIN (40 Mg) (View Simvastatin Review and Simvastatin Label ), ATENOLOL (50 Mg) (View Atenolol Review and Atenolol Label ), PLAVIX (75 Mg) (View Plavix Review and Plavix Label ), DOXAZOSIN MESYLATE (4 Mg) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ).

6258073-X | Asthma
Patient was taking Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?) on Jun 26, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with hypertension and. Tekturna dosage: 150 Mg, Unk. During the same period patient was treated with AMLODIPINE (10, Unk) (View Amlodipine Review and Amlodipine Label ), DIOVAN (320, Unk) (View Diovan Review and Diovan Label ), HYDROCHLOROTHIAZIDE (25. Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6248758-3 | Dizziness, Extrasystoles, Hyperhidrosis, Palpitations, Tachycardia
Adverse event was reported on Jun 23, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension and. Location: UNITED STATES , weighting 135.0 lb, Patient had the following side effects: dizziness (What is dizziness?), extrasystoles, hyperhidrosis, palpitations, tachycardia. During the same period patient was treated with POTASSIUM CHLORIDE (Unk) (View Potassium Chloride Review and Potassium Chloride Label ), VITAMINS (1 Daily) (View Vitamins Review and Vitamins Label ).

6237457-X | Cerebrovascular Accident
on Jun 09, 2009 Female patient from UNITED STATES , 80 years of age, was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: cerebrovascular accident. Tekturna dosage: . During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ).

6229784-7 | Activities Of Daily Living Impaired, Asthenia, Atrial Fibrillation, Blood Pressure Increased, Chest Pain, Confusional State, Disturbance In Attention, Extrasystoles
on Jun 10, 2009 Male patient from UNITED STATES , 52 years of age, weighting 222.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, asthenia, atrial fibrillation (What is atrial fibrillation?), blood pressure increased, chest pain (What is chest pain?), confusional state, disturbance in attention, extrasystoles. Tekturna dosage: 150 Mg, Qd. Patient was hospitalized.

6229744-6 | Tachycardia
Patient was taking Tekturna (View Usage). Patient had the following side effects: tachycardia on Jun 05, 2009 from UNITED STATES Additional patient health information: Male patient , 37 years of age, . Tekturna dosage: 1/2 Of 150mg, Qhs (single Episode). During the same period patient was treated with DIOVAN HCT (320val/25hct, Unk) (View Diovan Hct Review and Diovan Hct Label ), BYSTOLIC (View Bystolic Review and Bystolic Label ).